Mouse Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ELISA Kit

Studies of melanoma susceptibility, pancreatic adenocarcinoma biology, glioblastoma signaling, and cellular senescence in mouse models frequently require quantitative monitoring of the p16INK4a tumor suppressor protein encoded by the CDKN2A gene. This immunoassay kit from Assay Genie delivers quantitative measurement of mouse CDKN2A in tissue homogenates and related research specimens, supporting investigations into cell cycle regulation, G1/S checkpoint control, and retinoblastoma pathway activity. The kit supports 96 individual determinations arranged in a microplate configuration, enabling parallel processing of biological replicates and treatment cohorts in standard ELISA workflows.

Researchers apply the assay to track cyclin-dependent kinase inhibitor expression across experimental conditions, including oncogene-induced senescence, tumor suppressor loss-of-function studies, and age-related proliferative decline. Reagents are calibrated for mouse reactivity, and the procedure is intended strictly for research use only. Each kit includes the necessary components for absorbance-based quantification, providing a reliable tool for translational cancer research, biomarker discovery, and studies of cell cycle dysregulation in murine model systems.